Ralph Wong

5.2k total citations · 1 hit paper
36 papers, 3.4k citations indexed

About

Ralph Wong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Ralph Wong has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Economics and Econometrics. Recurrent topics in Ralph Wong's work include Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Ralph Wong is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Ralph Wong collaborates with scholars based in Canada, United States and Australia. Ralph Wong's co-authors include Sheryl Koski, Werner Scheithauer, Eduardo Díaz‐Rubio, Arié Figer, Leonard B. Saltz, Stephen Clarke, Jim Cassidy, Félix Couture, Tsai‐Shen Yang and Mikhail Lichinitser and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

Ralph Wong

35 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

2008 2.3k citations Leonard B. Saltz, Stephen Clarke et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Wong Canada	18	2.8k	1.2k	953	513	487	36	3.4k
Ludwig Fischer von Weikersthal Germany	28	2.3k 0.8×	1.2k 1.1×	488 0.5×	391 0.8×	641 1.3×	149	2.7k
Sylvain Manfrédi France	28	2.3k 0.8×	1.2k 1.1×	754 0.8×	1.3k 2.5×	543 1.1×	117	3.5k
Ilhan Celik Germany	15	2.8k 1.0×	1.6k 1.4×	580 0.6×	682 1.3×	911 1.9×	31	3.9k
Mark Kozloff United States	36	3.2k 1.1×	1.7k 1.4×	454 0.5×	612 1.2×	593 1.2×	125	4.7k
Jean–Luc Van Laethem Belgium	20	3.1k 1.1×	1.5k 1.3×	559 0.6×	817 1.6×	635 1.3×	50	3.8k
Michelle R. Mahoney United States	32	3.4k 1.2×	1.7k 1.5×	934 1.0×	1.2k 2.2×	1.3k 2.7×	71	4.8k
D. Papamichael United Kingdom	15	3.0k 1.1×	958 0.8×	916 1.0×	817 1.6×	567 1.2×	26	3.7k
Claus‐Henning Köhne Germany	27	3.1k 1.1×	1.2k 1.0×	1.1k 1.2×	750 1.5×	627 1.3×	75	4.3k
O. Kisker Germany	28	2.0k 0.7×	876 0.8×	492 0.5×	555 1.1×	376 0.8×	43	3.3k
Frank Cihon United States	18	2.5k 0.9×	1.6k 1.4×	920 1.0×	329 0.6×	679 1.4×	33	3.8k

Countries citing papers authored by Ralph Wong

Since Specialization

Citations

This map shows the geographic impact of Ralph Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Wong more than expected).

Fields of papers citing papers by Ralph Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Wong. The network helps show where Ralph Wong may publish in the future.

Co-authorship network of co-authors of Ralph Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Wong. A scholar is included among the top collaborators of Ralph Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Wong. Ralph Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Arjun, Christopher J. O’Callaghan, Liting Zhu, et al.. (2024). The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17. JNCI Journal of the National Cancer Institute. 116(8). 1313–1318. 7 indexed citations

Mete, Özgür, Andrée Boucher, Kasmintan A. Schrader, et al.. (2024). Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocrine Pathology. 35(4). 293–308. 16 indexed citations

Sehdev, Sandeep, Nigel S. B. Rawson, Marcus O. Butler, et al.. (2024). Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. 31(4). 1803–1816. 4 indexed citations

Cortez, Eliane, Lani Clinton, Amanda Hemmerich, et al.. (2022). A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal Tumors and Comprehensive Genomic Profiling Analysis of 20 Cases. Current Oncology. 29(2). 1279–1297. 11 indexed citations

Ko, Y.J., Mahmoud Abdelsalam, Petr Kavan, et al.. (2019). What Is a Clinically Meaningful Survival Benefit in Refractory Metastatic Colorectal Cancer?. Current Oncology. 26(2). 255–259. 5 indexed citations

O’Callaghan, Christopher, Christos S. Karapetis, Timothy Price, et al.. (2018). Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response. Current Oncology. 25(6). 516–526. 13 indexed citations

Kim, Christina, Shahid Ahmed, Haji Chalchal, et al.. (2018). Report from the 19th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29–30 September 2017. Current Oncology. 25(4). 275–284. 1 indexed citations

Brule, Stephanie Yasmin, Derek J. Jonker, Christos S. Karapetis, et al.. (2015). Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. European Journal of Cancer. 51(11). 1405–1414. 253 indexed citations

Kollmannsberger, Christian, Denis Soulières, Ralph Wong, et al.. (2012). Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Canadian Urological Association Journal. 1(2S). S41–54. 97 indexed citations

10.

Sherman, Morris, Kelly W. Burak, Jean A. Maroun, et al.. (2011). Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Current Oncology. 18(5). 228–240. 48 indexed citations

11.

Cooke, Andrew, et al.. (2011). Treatment of Cardiac Angiosarcoma with Radiation and Docetaxel: A Case Report with Partial Response and Prolonged Stable Disease. Journal of Thoracic Oncology. 6(4). 834–835. 22 indexed citations

12.

Kocha, Walter, Jean A. Maroun, Hagen F. Kennecke, et al.. (2010). Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group. Current Oncology. 17(3). 49–64. 33 indexed citations

13.

Cripps, C., Sharlene Gill, Shahid Ahmed, et al.. (2010). Consensus Recommendations for the Use of Anti-EGFR Therapies in Metastatic Colorectal Cancer. Current Oncology. 17(6). 39–45. 7 indexed citations

14.

Saltz, Leonard B., Stephen Clarke, Eduardo Díaz‐Rubio, et al.. (2008). Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study. Journal of Clinical Oncology. 26(12). 2013–2019. 2275 indexed citations breakdown →

15.

Spano, Jean‐Philippe, Catherine Chodkiewicz, Joan Maurel, et al.. (2007). A randomized phase II study of axitinib (AG-013736) and gemcitabine versus gemcitabine in advanced pancreatic cancer, preceded by a phase I component. Journal of Clinical Oncology. 25(18_suppl). 4551–4551. 14 indexed citations

16.

Scheithauer, Werner, J Cassidy, Arié Figer, et al.. (2007). A comparison of medical resource use for 4 chemotherapy regimens as first-line treatment for metastatic colorectal cancer (MCRC): XELOX vs. FOLFOX4 ± bevacizumab (A). Journal of Clinical Oncology. 25(18_suppl). 4098–4098. 9 indexed citations

17.

Smylie, Michael, Ralph Wong, Catalin Mihalcioiu, Chris Lee, & Jean‐François Pouliot. (2006). A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma. Investigational New Drugs. 25(2). 155–159. 36 indexed citations

18.

Wong, Ralph, Tara Baetz, Marianne Krahn, et al.. (2006). SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Investigational New Drugs. 24(4). 347–351. 1 indexed citations

19.

Shah, Amil M., et al.. (2005). Surrogate Endpoints in Colorectal Cancer. Current Oncology. 12(4). 136–146. 1 indexed citations

20.

Wong, Ralph, et al.. (1995). Familial adenomatous polyposis and lung cancer. Journal of Surgical Oncology. 60(3). 213–214. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact